Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

Q2 2025 Earnings Call Transcript July 31, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...

Q2 2025 Management View CEO Christopher S. Boerner highlighted, "Our growth portfolio delivered another strong quarter with sales increasing 17% year-over-year, primarily driven by demand across all ...

Bristol Myers Squibb had a strong quarter, with key drugs old and new coming in either above or in line with Wall Street’s ...

Novo Nordisk promoted Maziar Mike Doustdar to president and CEO, effective August 7. The Food and Drug Administration tapped newly appointed George Tidmarsh as acting Center for Biologics Evaluation ...

From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July 2025.

Mboko, making her main draw debut on home soil, powered her way past Australia’s Kimberly Birrell 7-5, 6-3 on a scorching afternoon on IGA Stadium’s Centre Court.

Cristian Totti: A Career Under Pressure The challenges of living up to a famous surname have led Cristian Totti to end his football career at a young age, opting instead to nurture new talents.

US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief medical officer and head of development, effective August 1, 2025.

Tottenham came from behind to earn a 2-2 draw with Wycombe Wanderers in a behind-closed-doors friendly at Hotspur Way. A late addition to Spurs’ pre-season schedule, the fixture was only ...

AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit Hirawat, on Aug. 1.

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...